Literature DB >> 18572246

Modulation of intracellular machinery by beta-glycolipids is associated with alteration of NKT lipid rafts and amelioration of concanavalin-induced hepatitis.

Gadi Lalazar1, Ami Ben Ya'acov, Adi Lador, Dan M Livovsky, Orit Pappo, Sarah Preston, Menahem Hareati, Yaron Ilan.   

Abstract

UNLABELLED: The integrity of lipid rafts in cell membranes is important for signal transduction. AIM: To determine the distinct effects of beta-glycolipids on the composition of lipid rafts in natural killer T (NKT) cells and on the level of expression of flotillin-2, leukocyte-specific protein tyrosine kinase (Lck), and STAT1-associated pathways.
METHODS: The effects of glycolipids were determined by composition analysis of the raft domains, FACS analysis of the distribution patterns for the raft ganglioside, GM1, and fluorescence microscopy of raft patching. To evaluate the effects of the immune environment on glycolipid-associated alteration of lipid rafts, hepatitis was induced by an intravenous injection of concanavalin A (ConA) in mice treated with various glycolipids.
RESULTS: The administration of beta-glucosylceramide, beta-lactosylceramide, and a combination of both significantly altered GM1 content in lymphocyte membranes in an environment-dependent manner. These effects were associated with altered expression levels of flotillin-2, Lck, and STAT1, and with a significant decrease in intrahepatic CD8+ lymphocyte trapping and the alleviation of ConA-induced hepatitis. The administration of alpha-glycolipids failed to induce similar effects.
CONCLUSIONS: The alteration in the expression levels of flotillin-2, Lck, and STAT1 that occurs concomitantly with changes in lipid raft composition and structure following the administration of beta-glycolipids in ConA-induced hepatitis is microenvironment-dependent and is associated with decreased intrahepatic CD8(+) T lymphocyte trapping and amelioration of immune-mediated hepatitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18572246     DOI: 10.1016/j.molimm.2008.05.009

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

Review 1.  Targeting the diverse immunological functions expressed by hepatic NKT cells.

Authors:  Caroline C Duwaerts; Stephen H Gregory
Journal:  Expert Opin Ther Targets       Date:  2011-05-13       Impact factor: 6.902

2.  Beta-glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis.

Authors:  W Zhang; Y Moritoki; K Tsuneyama; G-X Yang; Y Ilan; Z-X Lian; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

3.  Short-Term Cohousing of Sick with Healthy or Treated Mice Alleviates the Inflammatory Response and Liver Damage.

Authors:  Yehudit Shabat; Yoav Lichtenstein; Yaron Ilan
Journal:  Inflammation       Date:  2020-09-25       Impact factor: 4.092

4.  Alpha versus beta: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells?

Authors:  Y Ilan
Journal:  Clin Exp Immunol       Date:  2009-09-30       Impact factor: 4.330

5.  The influence of membrane lipids in Staphylococcus aureus gamma-hemolysins pore formation.

Authors:  C Potrich; H Bastiani; D A Colin; S Huck; G Prévost; M Dalla Serra
Journal:  J Membr Biol       Date:  2008-12-09       Impact factor: 1.843

6.  Personalized inherent randomness of the immune system is manifested by an individualized response to immune triggers and immunomodulatory therapies: a novel platform for designing personalized immunotherapies.

Authors:  Madi El-Haj; Dimitri Kanovitch; Yaron Ilan
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

7.  Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance.

Authors:  Masashi Satoh; Yasuhiro Andoh; Christopher Stuart Clingan; Hisako Ogura; Satoshi Fujii; Koji Eshima; Toshinori Nakayama; Masaru Taniguchi; Noriyuki Hirata; Naoki Ishimori; Hiroyuki Tsutsui; Kazunori Onoé; Kazuya Iwabuchi
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

8.  Glycosphingolipids Prevent APAP and HMG-CoA Reductase Inhibitors-mediated Liver Damage: A Novel Method for "Safer Drug" Formulation that Prevents Drug-induced Liver Injury.

Authors:  Meir Mizrahi; Tomer Adar; Gadi Lalazar; Dean Nachman; Madi El Haj; Ami Ben Ya'acov; Yoav Lichtenstein; Yehudit Shabat; Dimitri Kanovich; Lida Zolotarov; Yaron Ilan
Journal:  J Clin Transl Hepatol       Date:  2018-02-14

9.  Oral Co-administration of Soy-derived Extracts with Alcohol or with Sugar-sweetened Beverages Exerts Liver and Sugar Protective Effects.

Authors:  Tawfik Khoury; Devorah Rotnemer-Golinkin; Yehudit Shabat; Lidya Zolotarovya; Yaron Ilan
Journal:  J Clin Transl Hepatol       Date:  2017-06-03

10.  The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathways.

Authors:  Yuval Ishay; Dvorah Rotnemer-Golinkin; Yaron Ilan
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.